RIVERVIEW MEDICAL CENTER — History
CCN 310034 | 3-year financial timeline | COVID resilience: 80/100
🛡️ Public data only — no PHI permitted on this instance.
$365M
Latest Revenue (FY2022)
+10.7%
Revenue CAGR (3yr)
5.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $298M | $350M | $365M | +4.4% | +10.7% |
| Operating Expenses | $309M | $341M | $345M | +1.2% | +5.7% |
| Operating Margin | -3.5% | 2.5% | 5.6% | +120.7% | +0.0% |
| Net Income | $-11M | $9M | $20M | +130.5% | +0.0% |
| Licensed Beds | 267 | 259 | 267 | +3.1% | +0.0% |
| Total Patient Days | 51,973 | 56,893 | 52,517 | -7.7% | +0.5% |
| Medicare Day % | 41% | 41% | 39% | -4.4% | -2.4% |
| Medicaid Day % | 4% | 3% | 4% | +34.9% | +4.3% |
COVID Impact & Recovery
Resilience Score: 80/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +22.6% ($298M → $365M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+10.7%
This Hospital
+7.6%
State Avg
Latest Margin
5.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $399M | 10.1% |
| FY2024 (proj) | $433M | 14.6% |
| FY2025 (proj) | $466M | 19.2% |